pharma news

News

Third death reported with a Sarepta gene therapy

A third fatality has been recorded among patients receiving treatment with a Sarepta gene therapy, adding to the troubles being faced by the company.

News

BMS, Pfizer take DTC route for blood thinner Eliquis

BMS, Pfizer launch direct-to-patient sales for anticoagulant Eliquis, as a report cites conflict-of-interest concerns about the emerging DTC channel.

News

GSK's growth plans dented by Blenrep setback

FDA advisors have voted that the benefit/risk profile of GSK's multiple myeloma therapy, Blenrep, does not support its approval in the US.

News

UK plans to invest 'billions' in Essex biosecurity centre

The UK government has revealed a plan to open a multibillion-pound biosecurity facility to protect the country from emerging public health threats.

News

Daniel Nadler, co-founder and chief executive of OpenEvidence

Medical chatbot firm OpenEvidence raises $210m

OpenEvidence has raised $210m to expand the capabilities of its physician decision-making tool and launch a new service offering 'PhD-level' research.

News

NICE relents and backs Kisqali for wide use in breast cancer

Novartis' breast cancer therapy Kisqali has been cleared for NHS use in early breast cancer, an indication driving blockbuster sales of the drug.

Third death reported with a Sarepta gene therapy

BMS, Pfizer take DTC route for blood thinner Eliquis

GSK's growth plans dented by Blenrep setback

UK plans to invest 'billions' in Essex biosecurity centre

Medical chatbot firm OpenEvidence raises $210m

NICE relents and backs Kisqali for wide use in breast cancer

Diagnostics lag is holding back new therapies, says study

Using AI-driven synthetic personas to take your insights fur...

pharma news

Editor's Picks